Barcelona’s Health Lean Analytics bags over €2.1 million to streamline hospital operations with AI and data analytics

Barcelona's Health Lean Analytics (HLA) has secured over €2.1 million in a financing round, signalling a significant push to enhance hospital operations through AI and data analytics. This funding, a blend of private investment and public support, will propel HLA's mission to automate data collection within healthcare settings and deliver actionable insights. The strategic involvement of Novanta, a US-listed company, as a technology and strategic partner is particularly noteworthy, providing HLA with crucial manufacturing and medical technology expertise, alongside access to the vital US market. The company’s advanced platform utilizes data automation, the Internet of Things, and artificial intelligence, with a particular focus on optimizing complex environments like surgical suites. HLA’s technology passively captures real-time clinical and operational data, integrating seamlessly with existing hospital systems to unify information on patients, materials, and equipment. By applying AI and large language models, HLA transforms raw data into intelligent, role-specific recommendations designed to increase efficiency, improve patient safety, and reduce operational costs within healthcare institutions. This significant funding round is set to bolster HLA's domestic market presence while aggressively driving its international expansion, with the United States slated as the primary strategic market for a commercial rollout within the next year. Furthermore, the investment will fuel continued advancements in HLA's R&D capabilities, strengthening its core platform in data automation, advanced analytics, and artificial intelligence. The company’s trajectory highlights Europe's growing capacity in developing sophisticated AI solutions for critical sectors, fostering digital sovereignty in vital industries.